Could Acadia use the p1 results from Neuren for Fragike X though - it would make sense from a safety perspective, but if that was the case then Neuren wouldn’t need to run any additional p1 trials fir the 3 additional indications they are running now, unless the dosage is different, but I don’t think it is…
- Forums
- ASX - By Stock
- Share Price
Could Acadia use the p1 results from Neuren for Fragike X though...
-
- There are more pages in this discussion • 839 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$19.43 |
Change
-0.560(2.80%) |
Mkt cap ! $2.505B |
Open | High | Low | Value | Volume |
$20.10 | $20.10 | $19.40 | $2.998M | 153.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 524 | $19.43 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.44 | 418 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 140 | 19.450 |
11 | 314 | 19.440 |
6 | 360 | 19.430 |
10 | 620 | 19.420 |
5 | 343 | 19.410 |
Price($) | Vol. | No. |
---|---|---|
19.460 | 432 | 9 |
19.470 | 354 | 6 |
19.480 | 508 | 8 |
19.490 | 572 | 8 |
19.500 | 1230 | 5 |
Last trade - 13.00pm 09/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |